Latest Revenue Guidance News

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Synertec Corporation Limited (ASX:SOP) reported a 19% revenue increase in FY26 alongside its first net operating cash inflow since FY19. The company raised approximately A$6 million through an institutional placement to support working capital and growth initiatives while reaffirming FY27 revenue guidance.

FINEOS Corporation Holdings PLC reported a robust half with 7.9% total revenue growth, a 32% jump in EBITDA, and a return to net profit driven by subscription sales and operational efficiencies.

Sco Technology forecasts a record FY26 with revenue up to NZ$296 million and operating EBITDA reaching NZ$36 million, reflecting strong progress on its ambitious Destination 2030 growth plan.

Life360 has surged past 100 million monthly active users, posting record revenue and subscriber growth in Q2 2026. Its AI-driven platform and expanding advertising business underpin strong profitability and a confident outlook.

DroneShield launches RfRecon, a portable AI-powered RF intelligence device designed to enhance situational awareness and decision-making in counter-drone missions. Initial customer engagement has begun with potential revenue expected in the second half of 2026.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

Synertec Corporation has affirmed that its recent announcements on a $4 million AGL contract and a 40-50% revenue growth forecast for FY27 were material and disclosed promptly, maintaining confidentiality until release.

Advanced Innergy Holdings (ASX:AIH) has revised down its FY26 revenue and EBITDA forecasts due to project timing delays and supply chain issues but maintains a robust order book and financial position.

Etherstack reports a 40% jump in first-half revenue to US$8.5 million, driven by strong trading momentum despite non-recurring expansion expenses. The company projects FY26 revenue between US$17.2 million and US$18.9 million amid ongoing growth initiatives.

Vista Group International posted a 12% revenue increase in 1H26, driven by cloud adoption and marquee client wins, prompting an upgrade to its full-year revenue forecast.

EBR Systems advanced its wireless cardiac pacing rollout in Q2 2026, completing 46 implants and signing 17 new purchasing contracts while shifting focus to deeper utilisation within existing accounts.